SCHEMBL4716886

SCHEMBL4716886

N=C(N)NCc1ccc(CN2CCc3ccccc3CC2CC(=O)O)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 2/20 0.42
ITGA5 P08648 2/20 0.42
KMT2A Q03164 4/20 0.41
TDP1 Q9NUW8 2/20 0.41
NR1D1 P20393 1/20 0.40
F2 P00734 4/20 0.39
OPRM1 P35372 5/20 0.39
OPRD1 P41143 3/20 0.39
OPRK1 P41145 3/20 0.39
MEN1 O00255 3/20 0.39
NPC1 O15118 1/20 0.39
MAPT P10636 2/20 0.38
ALDH1A1 P00352 1/20 0.38
ITGB3 P05106 1/20 0.37
ITGB2 P05107 1/20 0.37
ITGAV P06756 1/20 0.37
ITGA4 P13612 1/20 0.37
ITGAL P20701 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4715244 0.91 ITGB1 (0.40) ITGB1ITGA5KMT2ATDP1NR1D1
SCHEMBL4716885 0.76 SIGMAR1 (0.48) KMT2AF2MEN1HDAC1HDAC6
SCHEMBL4715032 0.75 GRIN1 (0.41) ITGB1ITGA5
SCHEMBL4714911 0.71 CD274 (0.37) ITGB1ITGA5MAPTALDH1A1ITGB3
SCHEMBL4715242 0.67 GRIN1 (0.46) KMT2AMEN1ITGB3
Bicarbonate SCHEMBL27358699 0.66 CYP2D6 (0.56) KMT2AF2MEN1ALDH1A1HDAC6
SCHEMBL8408488 0.66 GBA1 (0.48) ITGB1ITGA5KMT2AOPRD1ALDH1A1
SCHEMBL45768 0.65 CA12 (0.57) KMT2AMEN1MAPTALDH1A1
SCHEMBL11788673 0.64 ITGB3 (0.50) F2ALDH1A1ITGB3
Acetic Acid SCHEMBL28068598 0.64 CYP2C9 (0.53) KMT2AF2MEN1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1216230-B1 FUSED CYCLOHEPTANE AND FUSED AZACYCLOHEPTANE COMPOUNDS AND THEIR USE AS INTEGRIN RECEPTOR ANTAGONISTS AMGEN INC (US) 2008-04-23 EP disclosed
US-6514964-B1 Treating diseases, conditions or disorders mediated by integrin receptors, such as vitronectin and fibronectin receptors AMGEN INC. 2003-02-04 US disclosed